|
⚲
|
| Keyboard |
| Skybound Medtech Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002143631 |
| Sale | 2026-06-08 (1.2 M Offered, 1.2 M Sold) |
| Fund | |
| Phone | 2676700005 |
| Address | 1020 Holcombe Blvd Houston, TX 77030 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-09 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Matthew Kuhn | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Clover Partners LP
✚
|
TX | |
|
BB Investco GP LLC
✚
|
TX | |
|
Key Group Holdings USA Inc
✚
|
TX | |
|
Artemis Capital Advisers LP
✚
|
TX | |
|
SVB Financial Group
✚
|
TX | |
|
Verily Life Sciences LLC
✚
|
TX | |
|
Trust Ventures Capital LLC
✚
|
TX | |
|
McDaniel Terry & Co
✚
|
TX | |
|
Ventioneers LLC
✚
|
TX | |
|
WS Capital Management LP
✚
|
TX |